Medtronic PLC (MDT): Price and Financial Metrics
GET POWR RATINGS... FREE!
MDT POWR Grades
- MDT scores best on the Stability dimension, with a Stability rank ahead of 84.32% of US stocks.
- MDT's strongest trending metric is Growth; it's been moving down over the last 179 days.
- MDT ranks lowest in Momentum; there it ranks in the 19th percentile.
MDT Stock Summary
- With a market capitalization of $151,101,403,766, Medtronic plc has a greater market value than 98.51% of US stocks.
- Medtronic plc's stock had its IPO on January 1, 1986, making it an older stock than 92.84% of US equities in our set.
- With a year-over-year growth in debt of -17.04%, Medtronic plc's debt growth rate surpasses only 21.97% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Medtronic plc are CAT, DE, IBM, SYK, and GE.
- MDT's SEC filings can be seen here. And to visit Medtronic plc's official web site, go to www.medtronic.com.
MDT Valuation Summary
- In comparison to the median Healthcare stock, MDT's price/earnings ratio is 36.16% higher, now standing at 49.7.
- MDT's EV/EBIT ratio has moved up 7.6 over the prior 243 months.
- MDT's EV/EBIT ratio has moved up 7.6 over the prior 243 months.
Below are key valuation metrics over time for MDT.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MDT | 2021-08-31 | 6.0 | 3.5 | 49.7 | 42.2 |
| MDT | 2021-08-30 | 6.0 | 3.5 | 49.9 | 42.3 |
| MDT | 2021-08-27 | 6.0 | 3.5 | 49.9 | 42.2 |
| MDT | 2021-08-26 | 6.0 | 3.5 | 49.7 | 42.1 |
| MDT | 2021-08-25 | 6.0 | 3.5 | 50.1 | 42.5 |
| MDT | 2021-08-24 | 5.9 | 3.5 | 49.4 | 41.9 |
MDT Growth Metrics
- The 2 year cash and equivalents growth rate now stands at 12.84%.
- The 3 year price growth rate now stands at 18.11%.
- The 4 year revenue growth rate now stands at 0.28%.
The table below shows MDT's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2021-12-31 | 31,785 | 7,034 | 4,914 |
| 2021-09-30 | 31,797 | 7,162 | 4,704 |
| 2021-06-30 | 31,597 | 7,254 | 3,882 |
| 2021-03-31 | 30,117 | 6,240 | 3,606 |
| 2020-12-31 | 27,926 | 5,945 | 2,892 |
| 2020-09-30 | 27,868 | 5,996 | 3,537 |
MDT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MDT has a Quality Grade of C, ranking ahead of 63.82% of graded US stocks.
- MDT's asset turnover comes in at 0.334 -- ranking 125th of 186 Medical Equipment stocks.
- XRAY, BAX, and PEN are the stocks whose asset turnover ratios are most correlated with MDT.
The table below shows MDT's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-07-30 | 0.334 | 0.665 | 0.104 |
| 2021-04-30 | 0.317 | 0.652 | 0.102 |
| 2021-01-29 | 0.296 | 0.639 | 0.076 |
| 2020-10-30 | 0.299 | 0.646 | 0.086 |
| 2020-07-31 | 0.303 | 0.658 | 0.097 |
| 2020-04-24 | 0.316 | 0.674 | 0.116 |
MDT Price Target
For more insight on analysts targets of MDT, see our MDT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $145.56 | Average Broker Recommendation | 1.47 (Moderate Buy) |
MDT Stock Price Chart Interactive Chart >
MDT Price/Volume Stats
| Current price | $103.57 | 52-week high | $135.89 |
| Prev. close | $106.26 | 52-week low | $98.38 |
| Day low | $103.25 | Volume | 4,133,700 |
| Day high | $105.90 | Avg. volume | 6,245,091 |
| 50-day MA | $107.36 | Dividend yield | 2.37% |
| 200-day MA | $114.20 | Market Cap | 138.94B |
Medtronic PLC (MDT) Company Bio
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US. In 2015, Medtronic acquired Irish–tax registered Covidien (a U.S. tax inversion to Ireland from 2007), in the largest U.S. corporate tax inversion in history, which enabled Medtronic to move its legal registration from the U.S. to Ireland. Medtronic operates in 140 countries and employs over 104,950 people. (Source:Wikipedia)
Latest MDT News From Around the Web
Below are the latest news stories about Medtronic plc that investors may wish to consider to help them evaluate MDT as an investment opportunity.
Medtronic Posts Mixed Q3 Results; Shares Up 3%Medtronic Plc. (NYSE: MDT) an American-Irish medical devices company reported mixed results for its third quarter of fiscal 2022, ending January 28, 2022. Following the news, shares gained 3.1% to close at $103.72 on February 22. Despite the pandemic’s impact on healthcare procedural volumes, Medtronic delivered solid results aided by new product launches. The company even advanced its pipeline and won market share. Revenue across all of its segments, namely Cardiovascular, Medical Surgical, Neuroscience, and Diabetes, also reported mixed growth. Mixed Q3FY22 Results Medtronic’s adjusted earnings of $1.37 per share came in-line with the analyst estimates and grew 6% compared to the prior-year quarter. However, quarterly revenue of $7. |
Company News for Feb 23, 2022Companies in The News Are: MDT,CNP,WLK,CVI |
FDA Approves Medtronic's Recharge-Free Sacral Nerve Stimulation Therapy For Bladder, Bowel ControlThe FDA has approved Medtronic plc's (NYSE: MDT) InterStim X, the next generation of the InterStim portfolio's recharge-free device. InterStim systems deliver sacral neuromodulation (SNM) therapy. Recharge-free InterStim X or the rechargeable InterStim Micro device are used to treat overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. The InterStim X device with proprietary 5th generation battery chemistry offers more than ten years of battery life wi |
Medtronic: Market Share To Remain StableIn this analysis of Medtronic plc (MDT), we attributed the loss in its market share to Abbott (ABT) and Thermo Fisher Scientific (TMO) due to the lack of presence in the fast-growing IVD market. We also highlighted the company’s high-growth diabetes segment losing its competitive advantage with the introduction of... |
3 Stocks to Buy as Investors Double Down on Digital HealthThree digital health stocks are moving the needle for the fast-growing telehealth business. |
MDT Price Returns
| 1-mo | -6.03% |
| 3-mo | 3.59% |
| 6-mo | -10.55% |
| 1-year | -15.73% |
| 3-year | 26.33% |
| 5-year | 38.97% |
| YTD | 0.71% |
| 2021 | -9.79% |
| 2020 | 5.70% |
| 2019 | 27.34% |
| 2018 | 15.18% |
| 2017 | 15.90% |
MDT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching MDT
Want to do more research on Medtronic plc's stock and its price? Try the links below:Medtronic plc (MDT) Stock Price | Nasdaq
Medtronic plc (MDT) Stock Quote, History and News - Yahoo Finance
Medtronic plc (MDT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...